First Wave BioPharma Inc.

NASDAQ: FWBI · Real-Time Price · USD
2.96
0.13 (4.59%)
At close: May 16, 2024, 10:00 PM

First Wave BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-25.64M -33.45M -26.62M -14.63M -10.78M -6.16M -15.79M -15.68M -7.85M -9.07M -14.63M -21.82M -56.61M -60.48M -58.54M -64.77M -39.68M -35.1M
Depreciation & Amortization
51.35K 86.67K 98.96K 84.26K 62.25K 34.25K 29.27K 29.27K 29.27K 29.27K 29.27K 159.16K 290.1K 416.66K 542.25K 548.18K 549.99K 557.44K
Stock-Based Compensation
160.16K 292.05K 563.41K 718.79K 792.7K 953.52K 1.04M 998.7K 827.01K 909.21K 769.12K 787.14K 877.91K 817.06K 1.37M 1.42M 1.38M 1.25M
Other Working Capital
-2.06M -1.57M -1.64M 74.89K 1.27M 1.19M 1.51M 349.53K -8.78M -8.54M -8.51M 6.22M 14.88M 15.35M 15.69M 1.41M 1.31M 1.09M
Other Non-Cash Items
6.49M 13.82M 17.96M 15.1M 13.46M 4.89M 322.8K 1.93M 1.85M 1.86M 1.99M 2.87M 2.98M 2.57M 3.46M 699.05K 1.48M 4.16M
Deferred Income Tax
19.45M 23.7M 8.84M -6.35M -10.77M -15.03M -165.77K n/a n/a n/a n/a 3.77M 3.77M 3.77M 3.77M 10.95K 620.95K 620.95K
Change in Working Capital
-1.95M -2.08M -1.63M -451.15K 234.73K 1.8M 2.19M -1.81M -10.31M -11M -10.5M -8.39M 14.6M 17.78M 17.1M 29.77M 16.36M 13.5M
Operating Cash Flow
-1.43M -4.83M -7.76M -12.5M -13.97M -13.28M -12.38M -14.53M -15.45M -17.28M -22.34M -22.61M -34.09M -35.13M -32.29M -32.32M -19.28M -15M
Capital Expenditures
1M 1M 1M n/a -500K -500K -500K n/a n/a n/a n/a 1.96K -1.25M -1.32M -1.32M -1.32M -75.29K 173.00
Cash Acquisitions
-176.34K -264.51K -176.34K -88.17K n/a 88.17K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
176.34K 176.34K 264.51K 175.84K 87.67K 87.67K -500 n/a n/a n/a n/a n/a n/a -9M -9M -8.91M -8.91M 91.52K
Investing Cash Flow
1M 911.83K 1M n/a -500K -411.83K -500K n/a n/a n/a n/a 1.96K -1.25M -10.32M -10.32M -10.23M -8.98M 91.69K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-674.49K -615.26K -534K -293.04K -104.2K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-6.01M -1.67M 925.14K 10.3M 17.62M 15.06M 15.23M 16.39M 15.78M 13.92M 15.74M 17.04M 28.37M 39.08M 44.76M 38.49M 35.45M 25.34M
Financial Cash Flow
-8.97M -8.29M -5.61M 6.29M 13.81M 15.06M 15.23M 16.39M 15.78M 13.92M 15.74M 17.04M 28.37M 39.08M 44.76M 38.49M 35.45M 25.34M
Net Cash Flow
-6.46M -9.16M -9.32M -5.65M -552.06K 1.37M 2.35M 1.64M 102.56K -3.61M -6.86M -5.53M -6.92M -6.33M 2.19M -4.16M 7.09M 10.4M
Free Cash Flow
-433.76K -3.83M -6.76M -12.5M -14.47M -13.78M -12.88M -14.53M -15.45M -17.28M -22.34M -22.61M -35.34M -36.45M -33.61M -33.64M -19.36M -15M